Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4‐positive cells which co‐express cytolytic activity and production of interleukin‐2

International Journal of Cancer

Volumn 37, Issue 3, 1986, Pages 343-349

  Romagnani, S ^a   Maggi, E ^a   Parronchi, P ^a   Macchia, D ^a   Prete, G F Del ^a   Rossi Ferrini P L ^b   Ricci, M ^a   Moretta, L ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Division of Haematology   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

CELL CULTURE; CLONE; CYTOLYSIS; HODGKIN DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHATIC SYSTEM; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ANTIGENS, SURFACE; CLONE CELLS; CYTOTOXICITY, IMMUNOLOGIC; HLA ANTIGENS; HODGKIN DISEASE; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; PHENOTYPE; SPLEEN; T-LYMPHOCYTES;

EID: 0022568952     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910370304     Document Type: Article

References (32)

1. Lymph node T cells in Hodgkin's disease: analysis of suspensions with monoclonal antibody and rosetting techniques
2. A Hodgkin cell‐specific antigen is expressed on a subset of auto‐ and alloactivated T (helper) lymphoblasts
3. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens
4. T cell subpopulations required for the human cytotoxic T lymphocyte response to influenza virus: evidence for T cell help
5. Immunodeficiency in Hodgkin's disease and its relation to prognosis
6. Lymphocyte subpopulations in Hodgkin's disease
7. Report of the Committee of Hodgkin's Disease Staging Classification
8. Activation of human T lymphocytic subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens
9. Association of an interleukin abnormality with the T cell defect in Hodgkin's disease
10. T‐cell subsets in Hodgkin's disease: a study of peripheral blood, spleen and involved tissue
11. + human cytolytic T cell clones are restricted by class II HLA antigens
12. ‘Sternberg‐Reed’ giant cells of Hodgkin's disease: cultivation in vitro, heterotransplantation, and characterization as neoplastic macrophages
13. Increase of T lymphocytes in the spleen in Hodgkin's disease
14. Tissue culture studies in Hodgkin's disease. Morphologic, cytogenetic, cell surface and enzymatic properties of cultures derived from splenic tumors
15. + effector T cells recognize products of different major histocompatibility complex regions
16. + cytolytic clones
17. Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA‐DR expression and cytolytic activity
18. Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations
19. Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease
20. In situ immunologic characterization of cellular constituents in lymph nodes and spleens involved by Hodgkin's disease
21. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T‐cell lineage
22. Displacement of T lymphocytes with the ‘helper/inducer’ phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin's disease
23. Lymphocytes T et sous‐populations des lymphocytes T dans les ganglions lymphatiques de la maladie de Hodgkin
24. Production of a monoclonal antibody specific for Hodgkin and Sternberg‐Reed cells of Hodgkin's disease and a subset of normal lymphoid cells
25. Evidence of Sternberg‐Reed cells being derived from activated lymphocytes
26. The pathogenesis of Hodgkin's disease
27. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis
28. The nature of Reed‐Sternberg cells and other malignant ‘reticulum’ cells
29. Molecular interactions in human T‐cell mediated cytotoxicity to EBV. II. Monoclonal antibody OKT3 inhibits a post‐killer‐target recognition/adhesion step
30. +) exhibits the property of binding to NK cell targets and granular lymphocyte morphology
31. Peripheral blood Ia‐positive T cells. Increases in certain diseases and after immunization